Metabolon, Inc.

We’re excited to be at #ARVO2026 this week! Stop by Booth #6047 to meet the team and learn how metabolomics can help advance our understanding of retinal disease and support biomarker discovery.

Multiomics is reshaping biomarker discovery. Join our upcoming webinar with Dr. Vivek Das (Novo Nordisk), who will share how multiomics revealed signatures of plaque instability, and why metabolomics was key. 📅 May 19 | 🕑 10am EDT / 4pm CEST Register: bit.ly/48uyJyX

During #LabProfessionalsAppreciationWeek, we’re proud to recognize our Laboratory Operations team. Their expertise, precision, and collaboration turn complex science into trusted results and real impact. Thank you for everything you do, your work drives our progress every day.

Proud to see colleagues Dr. Adam Kennedy & Dr. Greg Michelotti leading a new Metabolites Special Issue: bit.ly/4sIFZyu “Advances in Metabolomics for Precision Medicine” explores earlier disease detection, new biomarkers, and improved tracking of therapeutic response.

Reliability is often overlooked in #metabolomics, but it shouldn’t be. At Metabolon, a systems-level approach to QC, harmonization, and maintenance reduces rework to ~3% and protects uptime. Operational excellence = better data, better outcomes. Read: bit.ly/4tKKaum

What turns insight into impact? Michael Irwin, our VP of Sales, shares why belief + disciplined execution drive real results. At Metabolon, that’s how we’re advancing metabolomics in the multiomics landscape. Read more: bit.ly/4bYAfeH

Live from #ADPD2026 Advancing Parkinson’s research by capturing real-time biochemical changes, in collaboration with @MichaelJFoxOrg. Come by booth #01C to learn more!

We are thrilled to join the #EPILifestyle26 conference in Boston this week and discuss how to leverage metabolomic analysis to dissect cardiometabolic risk in large-scale population studies. Meet Tony di Meco and Katherine Black at booth #6 between March 17th and 20th!

At #ADPD2026? Come by booth #01C to learn how metabolomics can support your neuroscience research.

We’re proud to announce our collaboration with The Michael J. Fox Foundation to advance multiomic analyses and biomarker discovery in Parkinson’s research, a disease where diagnosis and treatment remain challenging despite its prevalence. 🔗mtbln.co/fq53ts

Heading to #ADPD2026? Stop by booth #01C to see how metabolomics is advancing neuroscience research. 🔬 Reveal early disease biology 🧠 Discover biomarkers across 5,400+ metabolites 📊 Turn data into biological insight 📅 Mar 17–21 🤝 Book a meeting: mtbln.co/ugw7l7

How can metabolomics move beyond traditional biomarkers to better understand human health? This week, we are celebrating women in science, including our Head of R&D Dr. Annie Evans. 📖 Read her blog: mtbln.co/y5rly8 #InternationalWomensDay

Read the latest interview with Dr. Heino Heyman on how metabolomics revealed metabolic signatures linked to neurological events in CAR-T patients. lnkd.in/ezrSdvXr Do you want to implement metabolomics in your drug development workflows? Watch: mtbln.co/3gavtd

More: mtbln.co/azc4kw

What if inflammatory cytokines aren’t the best predictors of CAR-T neurotoxicity? Across 3,800+ samples from six trials, metabolomics revealed pathway-level disruptions that outperformed IL-6 and TNFα in predicting severe events. Disease progression shared metabolic drivers.

On #InternationalWomenAndGirlsInScienceDay, we celebrate the incredible women scientists at Metabolon. Special congratulations to Dr. Annie Evans and Dr. Natasa Giallourou, featured by @Metabolomics for their outstanding contributions to the field. Proud to work alongside you.

More about this announcement on the press release: mtbln.co/d3kucj

A new metabolite has joined the team! Help us welcome Andrew Messick, our new Chief Financial Officer. Drew brings more than 25 years of financial leadership experience in the life sciences and will be key as we continue to scale and advance our strategic growth initiatives.

Contact us today to learn more: mtbln.co/nzzd43

Read the paper here: link.springer.com/article/10.100…

Can dried blood spots (DBS) support scalable, minimally invasive, remote studies? A study published in @metabolomics shows that DBS captures exercise-induced metabolic changes with broad pathway coverage using Metabolon's platform.